Stay updated on MAPK Pathway Inhibitors in Hematologic Malignancies Clinical Trial

Sign up to get notified when there's something new on the MAPK Pathway Inhibitors in Hematologic Malignancies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the MAPK Pathway Inhibitors in Hematologic Malignancies Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The website has added new features for data selection and download options, while several key government health-related URLs have been removed.
    Difference
    14%
    Check dated 2024-11-23T04:27:21.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    New resources have been added, including links to major health and government websites such as HHS, NIH, NLM, NCBI, and USA.gov.
    Difference
    0.7%
    Check dated 2024-11-15T23:31:44.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The website has been updated to version v2.12.2, introducing new download options in various file formats and an extensive selection of data fields for studies.
    Difference
    16%
    Check dated 2024-11-08T18:12:55.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    The website has been updated from version 2.12.0 to 2.12.1.
    Difference
    0.3%
    Check dated 2024-11-01T10:30:07.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The website has been updated from version 2.11.2 to 2.12.0, indicating a new release with potential enhancements or features.
    Difference
    0.7%
    Check dated 2024-10-25T00:29:53.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    The website has been updated from version 2.11.0 to 2.11.2, indicating new features or improvements.
    Difference
    0.3%
    Check dated 2024-10-03T04:53:06.000Z thumbnail image

Stay in the know with updates to MAPK Pathway Inhibitors in Hematologic Malignancies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the MAPK Pathway Inhibitors in Hematologic Malignancies Clinical Trial page.